ArticleScientific reports2020

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study.

Byung-Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.